Validity and Reproducibility of OSND (Objective Score of Nutrition on Dialysis) as a Nutritional Marker in End-stage Renal Disease
NCT ID: NCT01214447
Last Updated: 2010-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2010-10-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low - OSND less than 22
No intervention
Observational study - no intervention
Moderate - OSND score 23-27
No intervention
Observational study - no intervention
Normal - OSND score 28-32
No intervention
Observational study - no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Observational study - no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Stable and adequate hemodialysis treatment three months prior to participation in study as defined by Kt/V \> 1.2 and/or hemodialysis performed 4 hours 3 times weekly
3. Patients with normal hydration status (edema-free), with no neuroid-muscular diseases
4. Informed consent obtained before any trial-related activities
Exclusion Criteria
2. Patients with active malignant disease or liver cirrhosis
3. Patients with neuroid-muscular diseases
4. Patients on chronic treatment with steroids on doses \> 10 mg/day Prednisone (or equivalent)
5. Patients treated with immunosuppressive agents
6. Patients suffering from
* Acute vasculitis
* Severe systemic infections
* Heart failure (NYHA class III-IV)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assaf-Harofeh Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nephrology Division, Assaf Harofeh Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ilia Beberashvili, MD
Role: PRINCIPAL_INVESTIGATOR
Nephrology division Assaf Harofeh Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assaf Harofeh Medical Center
Ẕerifin, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Beberashvili I, Azar A, Sinuani I, Yasur H, Feldman L, Averbukh Z, Weissgarten J. Objective Score of Nutrition on Dialysis (OSND) as an alternative for the malnutrition-inflammation score in assessment of nutritional risk of haemodialysis patients. Nephrol Dial Transplant. 2010 Aug;25(8):2662-71. doi: 10.1093/ndt/gfq031. Epub 2010 Feb 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
132/10
Identifier Type: -
Identifier Source: org_study_id